A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, April 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma. https://t.co/YXs0AFfWT7 #DLBCL #lymsm #hematology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.